Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Respiratory and Critical Care Medicine|August 1, 2025
Addressing Sex as a Biological Variable in Preclinical Models of Lung Disease: An Official American Thoracic Society Research StatementKrithika Lingappan, Isaac Kirubakaran Sundar, Y S Prakash, et al.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2019
Improving the Quality and Reproducibility of Flow Cytometry in the Lung. An Official American Thoracic Society Workshop ReportRobert M Tighe, Elizabeth F Redente, Yen-Rei Yu, et al.
Respirology (Carlton, Vic.)|August 29, 2023
Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CTPFAV ) in idiopathic pulmonary fibrosisMarissa O'Callaghan, John Duignan, Elizabeth J Tarling, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2018
Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary FibrosisAlison Bamberg, Elizabeth F Redente, Steve D Groshong, et al.
The American Journal of Pathology|March 22, 2014
Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsivenessYael Aschner, Anthony P Khalifah, Natalie Briones, et al.
The Journal of Clinical Investigation|January 2, 2025
Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epitheliumJames P Bridges, Eszter K Vladar, Jonathan S Kurche, et al.
The Journal of Clinical Investigation|September 28, 2023
Regulation of epithelial transitional states in murine and human pulmonary fibrosisFa Wang, Christopher Ting, Kent A Riemondy, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 4, 2020
Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblastsYael Aschner, Meghan Nelson, Matthew Brenner, et al.
Nature Communications|March 1, 2026
Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 InhibitionElizabeth F Redente, Tengyao Song, Nomin Javkhlan, et al.
Pageof 7